Trial ID or NCT#

NCT03137381

Status

RECRUITING

Purpose

This study will evaluate the safety and efficacy of CTP-543 in adult patients with chronic, moderate to severe alopecia areata.

Official Title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Eligibility Criteria

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Justin M Ko, MD, MBA, FAAD
Dermatologist, Melanoma specialist, Psoriasis specialist, Cutaneous oncology specialist
Clinical Associate Professor, Dermatology

Contact us to find out if this trial is right for you.

CONTACT

Michelle Kim
(650) 498-4880